{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T06:15:05Z","timestamp":1794982505146,"version":"4.9.1"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,8,30]],"date-time":"2021-08-30T00:00:00Z","timestamp":1630281600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,8,30]],"date-time":"2021-08-30T00:00:00Z","timestamp":1630281600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p><jats:italic>Borrelia burgdorferi<\/jats:italic> is the causative agent of Lyme borreliosis, which is the most common tick-borne human disease in Europe and North America. Currently, the diagnosis of Lyme borreliosis is based on serological tests allowing indirect detection of anti-<jats:italic>Borrelia<\/jats:italic> antibodies produced by patients. Their main drawback is a lack of sensitivity in the early phase of disease and an incapacity to prove an active infection. Direct diagnostic tests are clearly needed. The objectives of this study were to produce tools allowing sensitive detection of potential circulating <jats:italic>Borrelia<\/jats:italic> antigens and to evaluate them in a mouse model. We focused on two potential early bacterial makers, the highly variable OspC protein and the conserved protein FlaB. High-affinity monoclonal antibodies were produced and used to establish various immunoassays and western blot detection. A very good limit of detection for OspC as low as 17\u00a0pg\/mL of sample was achieved with SPIE-IA. In infected mice, we were able to measure OspC in plasma with a mean value of 10\u00a0ng\/mL at 7\u00a0days post-inoculation. This result suggests that OspC could be a good blood marker for diagnosis of Lyme borreliosis and that the tools developed during this study could be very useful.<\/jats:p>","DOI":"10.1038\/s41598-021-96861-z","type":"journal-article","created":{"date-parts":[[2021,8,30]],"date-time":"2021-08-30T10:02:57Z","timestamp":1630317777000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Detection of Borrelia burgdorferi antigens in tissues and plasma during early infection in a mouse model"],"prefix":"10.1038","volume":"11","author":[{"given":"Victoria","family":"Dolange","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"St\u00e9phanie","family":"Simon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathalie","family":"Morel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,8,30]]},"reference":[{"key":"96861_CR1","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1159\/000213069","volume":"37","author":"Z Hub\u00e1lek","year":"2009","unstructured":"Hub\u00e1lek, Z. Epidemiology of lyme borreliosis. Lyme Borreliosis 37, 31\u201350 (2009).","journal-title":"Lyme Borreliosis"},{"key":"96861_CR2","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/j.idc.2015.02.010","volume":"29","author":"PS Mead","year":"2015","unstructured":"Mead, P. S. Epidemiology of lyme disease. Infect. Dis. Clin. N. Am. 29, 187\u2013210 (2015).","journal-title":"Infect. Dis. Clin. N. Am."},{"key":"96861_CR3","first-page":"Doc03","volume":"18","author":"S Rauer","year":"2020","unstructured":"Rauer, S. et al. Guidelines for diagnosis and treatment in neurology\u2014Lyme neuroborreliosis. Ger. Med. Sci. 18, Doc03 (2020).","journal-title":"Ger. Med. Sci."},{"key":"96861_CR4","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.medmal.2018.11.011","volume":"49","author":"C Eldin","year":"2019","unstructured":"Eldin, C. et al. Review of European and American guidelines for the diagnosis of Lyme borreliosis. Med. Mal. Infect. 49, 121\u2013132 (2019).","journal-title":"Med. Mal. Infect."},{"key":"96861_CR5","doi-asserted-by":"publisher","first-page":"2472","DOI":"10.1056\/NEJM200306123482423","volume":"348","author":"AC Steere","year":"2003","unstructured":"Steere, A. C. & Sikand, V. K. The presenting manifestations of Lyme disease and the outcomes of treatment. N. Engl. J. Med. 348, 2472\u20132474 (2003).","journal-title":"N. Engl. J. Med."},{"key":"96861_CR6","doi-asserted-by":"publisher","first-page":"2794","DOI":"10.1056\/NEJMcp061181","volume":"354","author":"GP Wormser","year":"2006","unstructured":"Wormser, G. P. Clinical practice. Early Lyme disease. N. Engl. J. Med. 354, 2794\u20132801 (2006).","journal-title":"N. Engl. J. Med."},{"key":"96861_CR7","doi-asserted-by":"publisher","first-page":"114","DOI":"10.3389\/fimmu.2017.00114","volume":"8","author":"JA Hyde","year":"2017","unstructured":"Hyde, J. A. Borrelia burgdorferi keeps moving and carries on: A review of borrelial dissemination and invasion. Front. Immunol. 8, 114 (2017).","journal-title":"Front. Immunol."},{"key":"96861_CR8","first-page":"1","volume":"2","author":"AC Steere","year":"2016","unstructured":"Steere, A. C. et al. Lyme borreliosis. Nat. Rev. Disease Primers 2, 1\u201319 (2016).","journal-title":"Nat. Rev. Disease Primers"},{"key":"96861_CR9","first-page":"Doc14","volume":"15","author":"H Hofmann","year":"2017","unstructured":"Hofmann, H. et al. Cutaneous Lyme borreliosis: Guideline of the German Dermatology Society. Ger. Med. Sci. 15, Doc14 (2017).","journal-title":"Ger. Med. Sci."},{"key":"96861_CR10","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1016\/j.medmal.2019.05.006","volume":"49","author":"X Gocko","year":"2019","unstructured":"Gocko, X., Lenormand, C., Lemogne, K., Bouiller, K. & Gehanno, J.-F. Lyme borreliosis and other tick-borne diseases. Guidelines from the French scientific societies. Med. Mal. Infect. 49, 296\u2013317 (2019).","journal-title":"Med. Mal. Infect."},{"key":"96861_CR11","doi-asserted-by":"publisher","first-page":"241","DOI":"10.3389\/fcimb.2020.00241","volume":"10","author":"E Talagrand-Reboul","year":"2020","unstructured":"Talagrand-Reboul, E., Raffetin, A., Zachary, P., Jaulhac, B. & Eldin, C. Immunoserological diagnosis of human borrelioses: Current knowledge and perspectives. Front. Cell Infect. Microbiol. 10, 241 (2020).","journal-title":"Front. Cell Infect. Microbiol."},{"key":"96861_CR12","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmi.2019.06.033","author":"A Raffetin","year":"2019","unstructured":"Raffetin, A. et al. Unconventional diagnostic tests for Lyme borreliosis: A systematic review. Clin. Microbiol. Infect. https:\/\/doi.org\/10.1016\/j.cmi.2019.06.033 (2019).","journal-title":"Clin. Microbiol. Infect."},{"key":"96861_CR13","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1186\/s12879-016-1468-4","volume":"16","author":"MMG Leeflang","year":"2016","unstructured":"Leeflang, M. M. G. et al. The diagnostic accuracy of serological tests for Lyme borreliosis in Europe: A systematic review and meta-analysis. BMC Infect. Dis. 16, 140 (2016).","journal-title":"BMC Infect. Dis."},{"key":"96861_CR14","doi-asserted-by":"publisher","first-page":"1052","DOI":"10.1093\/cid\/ciy614","volume":"68","author":"SE Schutzer","year":"2018","unstructured":"Schutzer, S. E. et al. Direct diagnostic tests for lyme disease. Clin. Infect. Dis. 68, 1052\u20131057 (2018).","journal-title":"Clin. Infect. Dis."},{"key":"96861_CR15","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/S1473-3099(04)01044-8","volume":"4","author":"S Yang","year":"2004","unstructured":"Yang, S. & Rothman, R. E. PCR-based diagnostics for infectious diseases: Uses, limitations, and future applications in acute-care settings. Lancet Infect. Dis. 4, 337\u2013348 (2004).","journal-title":"Lancet Infect. Dis."},{"key":"96861_CR16","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/j.idc.2015.02.004","volume":"29","author":"SL Arvikar","year":"2015","unstructured":"Arvikar, S. L. & Steere, A. C. Diagnosis and treatment of lyme arthritis. Infect. Dis. Clin. N. Am. 29, 269\u2013280 (2015).","journal-title":"Infect. Dis. Clin. N. Am."},{"key":"96861_CR17","doi-asserted-by":"publisher","first-page":"18","DOI":"10.3390\/tropicalmed6010018","volume":"6","author":"JA Quintero","year":"2021","unstructured":"Quintero, J. A., Attah, R., Khianey, R., Capitle, E. & Schutzer, S. E. Arthritis and diagnostics in lyme disease. Trop. Med. Infect. Disease 6, 18 (2021).","journal-title":"Trop. Med. Infect. Disease"},{"key":"96861_CR18","doi-asserted-by":"publisher","first-page":"1162","DOI":"10.1128\/jcm.29.6.1162-1170.1991","volume":"29","author":"DW Dorward","year":"1991","unstructured":"Dorward, D. W., Schwan, T. G. & Garon, C. F. Immune capture and detection of Borrelia burgdorferi antigens in urine, blood, or tissues from infected ticks, mice, dogs, and humans. J. Clin. Microbiol. 29, 1162\u20131170 (1991).","journal-title":"J. Clin. Microbiol."},{"key":"96861_CR19","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/S0002-9343(00)00701-4","volume":"110","author":"MS Klempner","year":"2001","unstructured":"Klempner, M. S. et al. Intralaboratory reliability of serologic and urine testing for Lyme disease. Am. J. Med. 110, 217\u2013219 (2001).","journal-title":"Am. J. Med."},{"key":"96861_CR20","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1186\/s12967-015-0701-z","volume":"13","author":"R Magni","year":"2015","unstructured":"Magni, R. et al. Application of Nanotrap technology for high sensitivity measurement of urinary outer surface protein A carboxyl-terminus domain in early stage Lyme borreliosis. J. Transl. Med. 13, 346 (2015).","journal-title":"J. Transl. Med."},{"key":"96861_CR21","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1128\/CMR.18.3.484-509.2005","volume":"18","author":"ME Aguero-Rosenfeld","year":"2005","unstructured":"Aguero-Rosenfeld, M. E., Wang, G., Schwartz, I. & Wormser, G. P. Diagnosis of lyme borreliosis. Clin. Microbiol. Rev. 18, 484\u2013509 (2005).","journal-title":"Clin. Microbiol. Rev."},{"key":"96861_CR22","doi-asserted-by":"publisher","first-page":"1254","DOI":"10.1074\/mcp.M114.046540","volume":"14","author":"G Schnell","year":"2015","unstructured":"Schnell, G. et al. Discovery and targeted proteomics on cutaneous biopsies infected by borrelia to investigate lyme disease. Mol. Cell Proteom. 14, 1254\u20131264 (2015).","journal-title":"Mol. Cell Proteom."},{"key":"96861_CR23","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/S0022-1759(99)00097-6","volume":"228","author":"H Volland","year":"1999","unstructured":"Volland, H. et al. A solid-phase immobilized epitope immunoassay (SPIE-IA) permitting very sensitive and specific measurement of angiotensin II in plasma. J. Immunol. Methods 228, 37\u201347 (1999).","journal-title":"J. Immunol. Methods"},{"key":"96861_CR24","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1111\/2049-632X.12119","volume":"70","author":"CG Earnhart","year":"2014","unstructured":"Earnhart, C. G. et al. Assessment of the potential contribution of the highly conserved C-terminal motif (C10) of Borrelia burgdorferi outer surface protein C (OspC) in transmission and infectivity. Pathog. Dis. 70, 176\u2013184 (2014).","journal-title":"Pathog. Dis."},{"key":"96861_CR25","doi-asserted-by":"publisher","first-page":"3474","DOI":"10.1128\/JCM.36.12.3474-3479.1998","volume":"36","author":"MJ Mathiesen","year":"1998","unstructured":"Mathiesen, M. J. et al. Peptide-based OspC enzyme-linked immunosorbent assay for serodiagnosis of lyme borreliosis. J. Clin. Microbiol. 36, 3474\u20133479 (1998).","journal-title":"J. Clin. Microbiol."},{"key":"96861_CR26","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1016\/S0731-7085(03)00560-0","volume":"34","author":"H Volland","year":"2004","unstructured":"Volland, H., Pradelles, P., Taran, F., Buscarlet, L. & Creminon, C. Recent developments for SPIE-IA, a new sandwich immunoassay format for very small molecules. J. Pharm. Biomed. Anal. 34, 737\u2013752 (2004).","journal-title":"J. Pharm. Biomed. Anal."},{"key":"96861_CR27","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1093\/genetics\/151.1.15","volume":"151","author":"IN Wang","year":"1999","unstructured":"Wang, I. N. et al. Genetic diversity of ospC in a local population of Borrelia burgdorferi sensu stricto. Genetics 151, 15\u201330 (1999).","journal-title":"Genetics"},{"key":"96861_CR28","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1038\/nrmicro2714","volume":"10","author":"JD Radolf","year":"2012","unstructured":"Radolf, J. D., Caimano, M. J., Stevenson, B. & Hu, L. T. Of ticks, mice and men: understanding the dual-host lifestyle of Lyme disease spirochaetes. Nat. Rev. Microbiol. 10, 87\u201399 (2012).","journal-title":"Nat. Rev. Microbiol."},{"key":"96861_CR29","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1128\/JCM.38.1.382-388.2000","volume":"38","author":"TG Schwan","year":"2000","unstructured":"Schwan, T. G. & Piesman, J. Temporal changes in outer surface proteins A and C of the lyme disease-associated spirochete, Borrelia burgdorferi, during the chain of infection in ticks and mice. J. Clin. Microbiol. 38, 382\u2013388 (2000).","journal-title":"J. Clin. Microbiol."},{"key":"96861_CR30","doi-asserted-by":"publisher","first-page":"4073","DOI":"10.1128\/IAI.66.9.4073-4079.1998","volume":"66","author":"MJ Mathiesen","year":"1998","unstructured":"Mathiesen, M. J. et al. The dominant epitope of Borrelia garinii outer surface protein C recognized by sera from patients with neuroborreliosis has a surface-exposed conserved structural motif. Infect. Immun. 66, 4073\u20134079 (1998).","journal-title":"Infect. Immun."},{"key":"96861_CR31","doi-asserted-by":"publisher","first-page":"3518","DOI":"10.1128\/IAI.67.7.3518-3524.1999","volume":"67","author":"G Seinost","year":"1999","unstructured":"Seinost, G. et al. Four clones of Borrelia burgdorferi Sensu Stricto cause invasive infection in humans. Infect. Immun. 67, 3518\u20133524 (1999).","journal-title":"Infect. Immun."},{"key":"96861_CR32","doi-asserted-by":"publisher","first-page":"e00153-10","DOI":"10.1128\/mBio.00153-10","volume":"1","author":"AG Barbour","year":"2010","unstructured":"Barbour, A. G. & Travinsky, B. Evolution and distribution of the ospC gene, a transferable serotype determinant of Borrelia burgdorferi. MBio 1, e00153-10 (2010).","journal-title":"MBio"},{"key":"96861_CR33","doi-asserted-by":"publisher","first-page":"7869","DOI":"10.1128\/IAI.73.12.7869-7877.2005","volume":"73","author":"CG Earnhart","year":"2005","unstructured":"Earnhart, C. G., Buckles, E. L., Dumler, J. S. & Marconi, R. T. Demonstration of OspC type diversity in invasive human lyme disease isolates and identification of previously uncharacterized epitopes that define the specificity of the OspC murine antibody response. Infect. Immun. 73, 7869\u20137877 (2005).","journal-title":"Infect. Immun."},{"key":"96861_CR34","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/S0923-2508(01)01186-X","volume":"152","author":"G Baranton","year":"2001","unstructured":"Baranton, G., Seinost, G., Theodore, G., Postic, D. & Dykhuizen, D. Distinct levels of genetic diversity of Borrelia burgdorferi are associated with different aspects of pathogenicity. Res. Microbiol. 152, 149\u2013156 (2001).","journal-title":"Res. Microbiol."},{"key":"96861_CR35","doi-asserted-by":"publisher","first-page":"2401","DOI":"10.1016\/j.vaccine.2019.02.007","volume":"37","author":"JR Izac","year":"2019","unstructured":"Izac, J. R. et al. Analysis of the antigenic determinants of the OspC protein of the Lyme disease spirochetes: Evidence that the C10 motif is not immunodominant or required to elicit bactericidal antibody responses. Vaccine 37, 2401\u20132407 (2019).","journal-title":"Vaccine"},{"key":"96861_CR36","doi-asserted-by":"publisher","first-page":"16719","DOI":"10.1038\/s41598-017-16749-9","volume":"7","author":"A Grillon","year":"2017","unstructured":"Grillon, A. et al. Identification of Borrelia protein candidates in mouse skin for potential diagnosis of disseminated Lyme borreliosis. Sci. Rep. 7, 16719 (2017).","journal-title":"Sci. Rep."},{"key":"96861_CR37","doi-asserted-by":"publisher","first-page":"3419","DOI":"10.1128\/IAI.71.6.3419-3428.2003","volume":"71","author":"TR Crother","year":"2003","unstructured":"Crother, T. R. et al. Antigenic composition of Borrelia burgdorferi during infection of SCID Mice. Infect. Immun. 71, 3419\u20133428 (2003).","journal-title":"Infect. Immun."},{"key":"96861_CR38","first-page":"263","volume":"139","author":"SW Barthold","year":"1991","unstructured":"Barthold, S. W., Persing, D. H., Armstrong, A. L. & Peeples, R. A. Kinetics of Borrelia burgdorferi dissemination and evolution of disease after intradermal inoculation of mice. Am. J. Pathol. 139, 263\u2013273 (1991).","journal-title":"Am. J. Pathol."},{"key":"96861_CR39","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/S0002-9343(99)80097-7","volume":"99","author":"JL Goodman","year":"1995","unstructured":"Goodman, J. L. et al. Bloodstream invasion in early Lyme disease: Results from a prospective, controlled, blinded study using the polymerase chain reaction. Am. J. Med. 99, 6\u201312 (1995).","journal-title":"Am. J. Med."},{"key":"96861_CR40","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1128\/jcm.33.3.602-608.1995","volume":"33","author":"I Demaerschalck","year":"1995","unstructured":"Demaerschalck, I. et al. Simultaneous presence of different Borrelia burgdorferi genospecies in biological fluids of Lyme disease patients. J. Clin. Microbiol. 33, 602\u2013608 (1995).","journal-title":"J. Clin. Microbiol."},{"key":"96861_CR41","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1007\/978-1-59259-257-9_6","volume":"80","author":"Y Frobert","year":"1998","unstructured":"Frobert, Y. & Grassi, J. Screening of monoclonal antibodies using antigens labeled with acetylcholinesterase. Methods Mol. Biol. 80, 57\u201368 (1998).","journal-title":"Methods Mol. Biol."},{"key":"96861_CR42","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1016\/S0006-291X(87)80533-8","volume":"144","author":"LL McLaughlin","year":"1987","unstructured":"McLaughlin, L. L. et al. Development, validation and application of an enzyme immunoassay (EIA) of atriopeptin. Biochem. Biophys. Res. Commun. 144, 469\u2013476 (1987).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"96861_CR43","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/0022-1759(89)90223-8","volume":"123","author":"J Grassi","year":"1989","unstructured":"Grassi, J. et al. Production of monoclonal antibodies against interleukin-1 alpha and -1 beta. Development of two enzyme immunometric assays (EIA) using acetylcholinesterase and their application to biological media. J. Immunol. Methods 123, 193\u2013210 (1989).","journal-title":"J. Immunol. Methods"},{"key":"96861_CR44","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/0006-2952(61)90145-9","volume":"7","author":"GL Ellman","year":"1961","unstructured":"Ellman, G. L., Courtney, K. D., Andres, V. & Feather-Stone, R. M. A new and rapid colorimetric determination of acetylcholinesterase activity. Biochem. Pharmacol. 7, 88\u201395 (1961).","journal-title":"Biochem. Pharmacol."},{"key":"96861_CR45","doi-asserted-by":"publisher","first-page":"1722","DOI":"10.3389\/fmicb.2018.01722","volume":"9","author":"N Sertour","year":"2018","unstructured":"Sertour, N. et al. Infection kinetics and tropism of Borrelia burgdorferi sensu lato in mouse after natural (via ticks) or artificial (needle) infection depends on the bacterial strain. Front. Microbiol. 9, 1722 (2018).","journal-title":"Front. Microbiol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-96861-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-96861-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-96861-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,3]],"date-time":"2022-12-03T13:17:34Z","timestamp":1670073454000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-96861-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8,30]]},"references-count":45,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,12]]}},"alternative-id":["96861"],"URL":"https:\/\/doi.org\/10.1038\/s41598-021-96861-z","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,8,30]]},"assertion":[{"value":"9 June 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 August 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 August 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"17368"}}